FDA Dental Products Panel
This article was originally published in The Gray Sheet
Executive Summary
Meeting Oct. 13 and 14 in Gaithersburg, Maryland. The panel's agenda includes discussion on: classification of muscle monitor devices; reclassification of dental mercury; bone filling and augmentation materials; dental ingredient labeling; and draft guidance documents for endosseous implants and temporomandibular joint implants